Sign In
Buy HIMS
$27.77
+0.730 (+2.70%)
At Close: Jul 31, 2026
What the FDA's Latest Proposal Means for Lilly, Novo, and Hims
10:05am, Thursday, 07'th May 2026
Eli Lilly and Company NYSE: LLY and Novo Nordisk A/S NYSE: NVO are two weight-loss and diabetes drug stocks that have been on completely different trajectories. Since the start of 2025, LLY is up near
Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note
06:46pm, Tuesday, 05'th May 2026
Hims & Hers Health, Inc. (HIMS) closed at $26.37 in the latest trading session, marking a -3.79% move from the prior day.
Hims & Hers Expands DTC Platform to Broaden Access to Personal Care
12:47pm, Tuesday, 05'th May 2026
HIMS broadens its DTC platform with GLP-1 access, a new Benefits hub and global expansion to broaden convenient, personalized care.
Hims Earnings: Stability Could Trigger A Squeeze
10:10am, Tuesday, 05'th May 2026
Hims guided Q1 revenue at $600–625 million with ~$65 million GLP-1 headwind, versus ~$616–650 million Street expectations. GAAP EPS expected to drop ~83% YoY to ~$0.03, implying margin reset alrea
Hims & Hers Health, Inc. (HIMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
11:06am, Monday, 04'th May 2026
Hims & Hers Health (HIMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HIMS vs. TDOC: Which Digital Health Stock Offers Better Upside Now?
01:50pm, Thursday, 30'th Apr 2026
Hims & Hers and Teladoc Health are taking different paths in digital health, but which stock offers stronger upside now? Let's dive in.
Hims & Hers Expands Digital-First Access to Personalized Healthcare
11:31am, Wednesday, 29'th Apr 2026
HIMS broadens digital-first care with Novo Nordisk GLP-1 access, new cancer detection and Labs tools, along with expansion into Canada and Europe.
Hims & Hers Health, Inc. (HIMS) is a Top-Ranked Momentum Stock: Should You Buy?
10:51am, Wednesday, 29'th Apr 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
OMCL vs. HIMS: Which Stock Should Value Investors Buy Now?
12:41pm, Tuesday, 28'th Apr 2026
Investors looking for stocks in the Medical Info Systems sector might want to consider either Omnicell (OMCL) or Hims & Hers Health, Inc. (HIMS). But which of these two companies is the best option fo
Amazon Takes a Bite Out of Hims: What Its GLP-1 Entrance Means
09:55am, Tuesday, 28'th Apr 2026
GLP-1 seller Hims & Hers Health NYSE: HIMS has seen significant volatility in its stock price as of late. Notably, despite seeing a 41% single-day surge in early March, HIMS remains down nearly 10% in
Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors
08:35am, Tuesday, 28'th Apr 2026
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, has nominated Kofi Amoo-Gottfried for election as a new director at
Hims & Hers Health, Inc. (HIMS) Stock Declines While Market Improves: Some Information for Investors
06:47pm, Monday, 27'th Apr 2026
The latest trading day saw Hims & Hers Health, Inc. (HIMS) settling at $29.39, representing a -3.83% change from its previous close.
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
10:02am, Monday, 27'th Apr 2026
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.
JPMorgan Initiates Hims & Hers With Overweight: Could the Novo Nordisk Deal Be the Turning Point?
12:01pm, Friday, 24'th Apr 2026
Hims & Hers Health (NYSE:HIMS) just picked up a high-profile endorsement.
Pre-Market Stock Futures: Futures are trading mixed as we get set to close out a wild week on Wall Street that saw a little bit of everything served with a massive helping of volatility. After a stell
